These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19189893)

  • 21. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
    van Veen WA
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal carcinoma: is screening possible?
    Bonelli L
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 25. Incremental advances in excremental cancer detection tests.
    Itzkowitz SH
    J Natl Cancer Inst; 2009 Sep; 101(18):1225-7. PubMed ID: 19700654
    [No Abstract]   [Full Text] [Related]  

  • 26. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of colorectal cancer screening.
    Hurst JS
    Am Fam Physician; 2003 Mar; 67(6):1188. PubMed ID: 12674445
    [No Abstract]   [Full Text] [Related]  

  • 29. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Age-specific detection rates of colorectal neoplasms by colonoscopic screening in high-incidence rural area].
    Li QL; Ma XY; Yu LL; Xue F; Ma WL; Yao KY
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):154-7. PubMed ID: 23714674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonoscopy as a mass screening tool.
    Lieberman D
    Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):225-8. PubMed ID: 9585025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U; Hundt S; Brenner H
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflationary caution in GI endoscopy.
    Sonnenberg A
    Gastrointest Endosc; 2010 Apr; 71(4):789-91. PubMed ID: 20363420
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of simply recording colonoscopy withdrawal time on polyp and adenoma detection rates.
    Taber A; Romagnuolo J
    Gastrointest Endosc; 2010 Apr; 71(4):782-6. PubMed ID: 20363418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Colon carcinoma: early detection and endoscopic prevention].
    Eickhoff A; Riemann JF
    Internist (Berl); 2000 Sep; 41(9):860-7. PubMed ID: 11006873
    [No Abstract]   [Full Text] [Related]  

  • 39. [Screening using Krypto-Haem-SSWR for the early detection of colorectal carcinomas and adenomas].
    Klug W; Knoch HG; Voboril Z
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(2):151-7. PubMed ID: 2263908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Judging the guidelines for colorectal cancer screening.
    Woolf SH; Ganiats TG
    Am Fam Physician; 1997 Jun; 55(8):2595, 2598-600. PubMed ID: 9191445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.